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Abstract
Comprehensive molecular-level models of human metabolism have
been generated on a cellular level. However, models of whole-body
metabolism have not been established as they require new
methodological approaches to integrate molecular and physiologi-
cal data. We developed a new metabolic network reconstruction
approach that used organ-specific information from literature and
omics data to generate two sex-specific whole-body metabolic
(WBM) reconstructions. These reconstructions capture the meta-
bolism of 26 organs and six blood cell types. Each WBM reconstruc-
tion represents whole-body organ-resolved metabolism with over
80,000 biochemical reactions in an anatomically and physiologi-
cally consistent manner. We parameterized the WBM reconstruc-
tions with physiological, dietary, and metabolomic data. The
resulting WBM models could recapitulate known inter-organ
metabolic cycles and energy use. We also illustrate that the WBM
models can predict known biomarkers of inherited metabolic
diseases in different biofluids. Predictions of basal metabolic rates,
by WBM models personalized with physiological data, outper-
formed current phenomenological models. Finally, integrating
microbiome data allowed the exploration of host–microbiome co-
metabolism. Overall, the WBM reconstructions, and their derived
computational models, represent an important step toward virtual
physiological humans.
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Introduction
A key aim of precision medicine is the development of predictive,
personalizable, and computational models of the human body that
can be interrogated to predict potential therapeutic approaches
(Kell, 2007). Molecular biology has yielded great insights into the
molecular constituents of human cells, but there still remains
substantial progress to be made to integrate these parts into a virtual
whole human body. While the Virtual Physiological Human and the
Physiome projects have generated many anatomically and physio-
logically representative human body models (Hunter et al, 2013),
their integration with underlying networks of genes, proteins, and
biochemical reactions (Tan et al, 2017) is relatively less developed.
The constraint-based reconstruction and analysis approach
(Palsson, 2015) generates a detailed description of molecular-level
processes through the construction of comprehensive, genome-scale
metabolic reconstructions. A reconstruction is assembled based on
an organism’s genome annotation and current biochemical and
physiological knowledge. A metabolic reconstruction is amenable to
computational modeling by the imposition of condition-specific
constraints based on experimental data, such as transcriptomics
(Opdam et al, 2017), proteomics (Yizhak et al, 2010), and metabo-
lomics (Aurich et al, 2016). Importantly, a metabolic reconstruction
serves as a blueprint for many condition-specific metabolic models,
making it a versatile tool for diverse biomedical applications (Aurich
& Thiele, 2016; Nielsen, 2017).
A comprehensive in silico molecular-level description of human
metabolism is available (Brunk et al, 2018); however, the genera-
tion of accurate organ- and tissue-specific metabolic models remains
challenging using automated approaches and omics data (Opdam
et al, 2017). At the same time, a solely manual curation approach
based on extensive literature review is not tractable due to the large
number of organs and cell types in the human body as well as the
variable depths of literature on organ-specific metabolic functions.
Hence, a combined algorithmic and manual curation approach is
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needed, which has already been developed for microbial reconstruc-
tions (Magnusdottir et al, 2017).
To contribute toward the ambitious goal to develop a human
whole-body model (Kitano, 2010), current systems biology
approaches need to go beyond molecular networks to also represent
anatomical and physiological properties in the computational
modeling framework. For instance, Bordbar et al (2011a) created
the first multi-tissue metabolic model where three organ-specific
metabolic models were connected through a blood compartment.
However, this model does not accurately describe the mass flow
occurring in the human body, which starts with dietary intake
followed by transport, metabolism, and elimination of the nutrients
and its by-products. In the absence of such detailed representation,
the generic human metabolic reconstruction has been used as a
proxy for whole-body metabolism (Nilsson et al, 2017), but it does
not yet capture metabolic pathways that occur in parallel in multiple
organs to give rise to known physiology, such as the Cori cycle.
To address these challenges, we developed the first two molecu-
lar-level, organ-resolved, physiologically consistent, sex-specific,
genome-scale reconstruction of whole-body metabolism (WBM;
Fig 1A). We demonstrate that these WBM reconstructions can be
converted into personalized WBM models by integration with physi-
ological, quantitative metabolomics, and microbiome data, thereby
allowing, e.g., the assessment of microbial metabolism on host
metabolism in an organ-resolved, person-dependent manner.
Results
A novel approach yields curated whole-body
metabolic reconstructions
We developed a novel, iterative approach to assemble WBM recon-
structions by leveraging an existing generic human metabolic recon-
struction, Recon3D (Brunk et al, 2018), reconstruction algorithms
(Vlassis et al, 2014), omics data (Wishart et al, 2013; Kim et al,
2014; Uhlen et al, 2015), and manual curation of more than 600
scientific literature articles and books (Fig 1A). The female WBM,
termed Harvetta 1.0, was generated by starting with a meta-recon-
struction, composed of a set of 30 identical Recon3D models
connected through anatomically consistent biofluid compartments
(Fig 1B, Materials and Methods, Reconstruction details). Similarly,
the male WBM, termed Harvey 1.0, started from a meta-reconstruc-
tion with one copy of Recon3D for each of its 28 organs, tissues,
and cell types (Table 1). Note that we will refer in the following to
all cell types, tissues, and organs collectively as organs. We exten-
sively reviewed organ-specific literature for genes, reactions, and
pathways known to be present in the different organs (Materials
and Methods, Reconstruction details, Table EV1). This review effort
yielded 9,258 organ-specific reactions, which we added to a core
reaction set, defining reactions that had to be present in the WBM
reconstructions. We removed 912 organ-specific reactions reported
to be absent in the literature (Materials and Methods, Reconstruc-
tion details, Table EV1). Moreover, evidence for the presence of
organ-specific proteins for all organs except the small intestine was
obtained from the human proteome map (Kim et al, 2014) and the
human proteome atlas (Uhlen et al, 2015) (Materials and Methods,
Reconstruction details, Tables EV2 and EV3). For four organs,
metabolic reconstructions have been published, namely the red
blood cell (Bordbar et al, 2011b), adipocyte (Bordbar et al, 2011a),
small intestine (Sahoo & Thiele, 2013), and liver (Gille et al, 2010).
Thus, we added the respective organ-specific reactions to the core
reaction set, after mapping the reaction identifiers to the Virtual
Metabolic Human (VMH, www.vmh.life) reaction identifiers (Mate-
rials and Methods, Reconstruction details). The literature was also
reviewed for the absence of cellular organelles in the different
organs (Materials and Methods, Reconstruction details, Table EV4),
which were removed accordingly from the relevant organs in the
meta-reconstructions. As a next step, we added transport reactions
to the core reaction set, based on organ-specific transporter expres-
sion data collected from the literature (Materials and Methods,
Reconstruction details, Table EV5; Sahoo et al, 2014), and organ-
specific sink reactions for metabolites known to be stored in dif-
ferent organs (Materials and Methods, Reconstruction details,
Tables EV6 and EV7). We used metabolomics data from 16 different
resources to enforce the presence of metabolites detected in the dif-
ferent biofluid compartments (Fig 1, Materials and Methods, Recon-
struction details, Table EV8), and added the corresponding reactions
to the core reaction set. Furthermore, we used literature information
to define metabolites that are known to cross, or not, the blood–
brain barrier and either added them to the core reaction set or
removed them from the meta-reconstructions, respectively (Mate-
rials and Methods, Reconstruction details, Table EV9). Additionally,
we included the dietary uptake reactions to the core reaction set for
metabolites that have been identified in food (Materials and Meth-
ods, Reconstruction details, Table EV10). Finally, to enable the inte-
gration of the gut microbiome with the WBM reconstructions (see
below), we added sink reactions to the core reaction set for metabo-
lites known to be produced by human gut microbes (Table EV11).
Each organ contains a biomass maintenance reaction representing
the macromolecular precursors (e.g., amino acids) required for
organ maintenance (Materials and Methods, Reconstruction details).
To represent the energy required to maintain the body’s cellular
function and integrity, we added a whole-body maintenance reac-
tion to both meta-reconstructions, in which each organ biomass
maintenance reaction is weighted based on its respective organ
weight in the reference man or woman (Snyder et al, 1975) (Mate-
rials and Methods, Reconstruction details).
The collected information, in the form of the core reaction set,
and the tailored meta-reconstructions were used as inputs for a
model extraction algorithm (Vlassis et al, 2014) to generate sex-
specific draft WBM reconstructions (Fig 1A, Materials and Methods,
Reconstruction details). This network extraction algorithm returns a
compact subnetwork containing all core reactions and a minimal
number of additional reactions necessary to render the subnetwork
flux consistent, i.e., each network reaction can carry a non-zero flux
value. As the algorithm adds a minimal number of reactions to the
subnetwork, it should be evaluated whether such additions can be
supported or rejected based on biological evidence. A similar
approach has been suggested for gap filling (Rolfsson et al, 2011).
Consequently, we revisited the literature for evidence to support
reaction inclusion and either expanded the organ-specific core reac-
tion set or removed organ-specific reactions from the meta-recon-
structions as appropriate (Fig 1A). We then generated new draft
WBM reconstructions using the model extraction algorithm with
this updated input. This cycle was iterated over a hundred times,
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Characteriscs of the WBM reconstrucons

























Organ weight based on 70 kg (male) & 58 kg (female) 58.8 kg (84%) 49.5 kg (85%)
Organ weight plus skeleton and connecve ssue (11kg) 69.3 kg (99%) 57.5 kg (99%)
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Figure 1. Overview of the reconstruction approach and key features of the organ-resolved, sex-specific, curated whole-body
metabolism (WBM) reconstructions.
A Overall approach to reconstruction and analysis of the WBM reconstructions and derived models. The generic genome-scale reconstruction of human metabolism,
Recon3D (Brunk et al, 2018), containing 13,543 metabolic reactions and 4,140 unique metabolites, was used to derive a stoichiometrically and flux-consistent
submodel, named Recon3*, to serve as a starting point for the construction of the WBM reconstructions. During the reconstruction process, we reviewed over 600
publications and included numerous omics data sets. myHarvey refers to the microbiome-associated WBM models. See Materials and Methods and Dataset EV2 for
more details.
B Schematic overview of the included organs and their anatomical connections in the male WBM reconstruction. The arrows indicate the organ exchange with the
biofluid compartments.
C Statistics of the content of the WBM reconstructions.
D Stoichiometric matrix of the male reconstruction is shown with all non-zero entries highlighted. The columns of the stoichiometric matrix represent the reactions,
while the rows correspond to the metabolites. If a metabolite (j) participates in a reaction (i), the stoichiometric coefficient is entered in the corresponding cell (i, j).
Each row represents the mass-balance equation for a given metabolite (dx/dt). In flux balance analysis (FBA) (Orth et al, 2010), the modeled system is assumed to be
at a steady state (i.e., dx/dt = 0). This mathematical problem can be efficiently solved at a large-scale (Materials and Methods, Conversion from reconstruction to
condition-specific models).
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focusing on different organs and metabolic pathways each time,
which was necessary due to the large size of the reconstructions
(Materials and Methods, Reconstruction details). Throughout the
reconstruction process, we followed an established quality control
and quality assurance protocol (Thiele & Palsson, 2010) and
performed core tests proposed by the systems biology community
(preprint: Lieven et al, 2018).
The final sex-specific WBM reconstructions account for 83,521
and 81,094 reactions for Harvetta and Harvey, respectively (Fig 1C,
Tables EV12 and EV13). Harvetta contained more reactions than
Harvey due to two more sex-specific organs (Fig 1C and D). In total,
73,215 reactions were shared between both sexes, while 7,879 were
unique to Harvey and 10,306 unique to Harvetta. Excluding sex
organs, < 4% of all WBM reactions were sex-specific, mostly
involving alternative transport reactions (Dataset EV2: 3.6). Overall,
these WBM reconstructions account for about 84% of the body
weight. The remaining 16% correspond mostly to bones and
connective tissue (Snyder et al, 1975; Fig 1C), both of which are as
yet insufficiently represented with corresponding reactions in
Recon3D. The resulting, sex-specific WBM reconstructions compre-
hensively capture human whole-body metabolism consistent with
current knowledge.
An organ compendium was derived from the
WBM reconstructions
A compendium of organ-specific reconstructions was extracted from
the WBM reconstructions (Figs 1B and 2, Tables 1 and EV14). All
organ-specific reconstructions can be obtained from the VMH at
www.vmh.life. The technical quality of each organ was assessed
using a comprehensive test suite, implemented in the COBRA Tool-
box (Heirendt et al, 2019), that checks for adherence to quality stan-
dards developed for metabolic reconstructions (Thiele & Palsson,
2010; Brunk et al, 2018; preprint: Lieven et al, 2018). These tests
included, e.g., testing for realistic ATP yields on various carbon
sources under aerobic and anaerobic conditions or the ability to
perform defined metabolic tasks (Dataset EV2: 3.7). A typical organ
contained 2,947  1,980 reactions, 2,076  1,081 metabolites, and
1,298  245 genes (average  SD, Fig 2A). As one would expect,
the organs with the most reactions were liver, kidney, and colon
(Fig 1D). On average, 72% of reactions in each organ were gene-
associated, when excluding transport and exchange reactions
(Fig 2A). About 10% of all metabolites were organ-specific metabo-
lites (Fig 2B), which may be used as biomarker metabolites for
organ dysfunction. Notably, an additional 330 metabolites could
only be found in two organs, potentially further expanding the set
of potential organ dysfunction markers. Only 176 (10%) of the
genes were core genes, which can be explained by the absence of
the mitochondrially localized gene products from the core set, as
the RBCs are lacking this organelle. When excluding the RBCs, an
additional 142 genes were present in all remaining organs. The
organ compendium represents a comprehensive set of manually
curated, self-consistent organ-specific reconstructions that may be
used for a range of biomedical applications (Aurich & Thiele, 2016;
Nielsen, 2017).
Combining metabolism with physiology enables physiologically
constrained, stoichiometric modeling
The conversion of a reconstruction into a model involves the impo-
sition of condition-specific constraints (Orth et al, 2010). Each
WBM reconstruction was constrained with 15 physiological parame-
ters (Fig 3A) and metabolomics data (Wishart et al, 2013; Materials
and Methods, Conversion from reconstruction to condition-specific
models, Dataset EV2: 3.2). For instance, metabolite transport across
the capillaries of well-perfused organs is bulk flow limited rather
than diffusion-limited (Feher, 2012). Using organ-specific blood flow
rates at rest (Price et al, 2003) and plasma metabolite concentra-
tions (Wishart et al, 2013), we placed upper bounds on the corre-
sponding organ-specific metabolite transport reactions. Hence, by
combining physiological and metabolomic constraints, we defined
how much of each metabolite can be maximally taken up by an







Adipose tissue Adipocytes_ Harvey, Harvetta
Adrenal gland Agland_ Harvey, Harvetta
B-cells Bcells_ Harvey, Harvetta
Brain Brain_ Harvey, Harvetta
Breast Breast_ Harvetta
CD4+ T-cells CD4Tcells_ Harvey, Harvetta
Cervix Cervix_ Harvetta
Colon Colon_ Harvey, Harvetta
Gallbladder Gall_ Harvey, Harvetta
Heart Heart_ Harvey, Harvetta
Kidney Kidney_ Harvey, Harvetta
Liver Liver_ Harvey, Harvetta
Lung Lung_ Harvey, Harvetta
Monocytes Monocyte_ Harvey, Harvetta
Muscle Muscle_ Harvey, Harvetta
Natural killer cells Nkcells_ Harvey, Harvetta
Ovary Ovary_ Harvetta
Pancreas Pancreas_ Harvey, Harvetta
Platelet Platelet_ Harvey, Harvetta
Prostate Prostate_ Harvey
Parathyroid gland Pthyroidgland_ Harvey, Harvetta
Red blood cell RBC_ Harvey, Harvetta
Retina Retina_ Harvey, Harvetta
Spinal cord Scord_ Harvey, Harvetta
Small intestine sIEC_ Harvey, Harvetta
Skin Skin_ Harvey, Harvetta
Spleen Spleen_ Harvey, Harvetta
Stomach Stomach_ Harvey, Harvetta
Testis Testis_ Harvey
Thyroid gland Thyroidgland_ Harvey, Harvetta
Urinary bladder Urinarybladder_ Harvey, Harvetta
Uterus Uterus_ Harvetta
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organ in the WBM, thereby addressing the challenge of appropri-
ately constraining organ-specific models. Additionally, we assumed
that the kidney filters 20% of blood plasma along with all the
metabolites, irrespective of their nature (Martini & Bartholomew,
2006). Accordingly, multiplying the glomerular filtration rate by
healthy plasma metabolite concentration ranges (Wishart et al,
2013) allowed us to set lower and upper bounds for filtration of
each metabolite by the kidney. Similarly, we assumed that cere-
brospinal fluid (CSF) metabolites are unselectively returned into the
bloodstream, permitting us to use healthy CSF metabolite concentra-
tion (Wishart et al, 2013) as constraints on the rate at which CSF
metabolites enter the bloodstream. Using the daily urine excretion
rate and urine metabolite concentrations (Wishart et al, 2013), we
constrained the rate of urinary metabolite excretion (Fig 3A). We
also applied constraints corresponding to an average European diet
(Fig 3B; Elmadfa, 2012). All applied constraints are described in
detail in the Dataset EV2: 3.2.1. In total, 12.5% of the WBM model
reactions had a constraint placed on their bounds, leading to a
substantially reduced steady-state solution flux space (Appendix Fig
S1A, Table EV12). We will refer to this novel paradigm in
constraint-based modeling as physiologically and stoichiometrically
constrained modeling (PSCM) and provide a PSCM toolbox (openc
obra.github.io/cobratoolbox) as well as a MATLAB (Mathworks,
Inc.) Live Script (Dataset EV2, https://opencobra.github.io/cobra
toolbox/stable/) enabling the reproducibility of all presented simu-
lations.
The physiologically constrained whole-body metabolic models
can predict organ metabolic essentiality, known biomarkers of
inherited metabolic diseases, and inter-organ metabolic cycles
To assess the predictive potential of the WBM models against current
knowledge, we computed the metabolic essentiality of an organ by
maximizing a whole-body maintenance reaction, without the corre-
sponding organ biomass contribution, under the aforementioned
physiological and dietary constraints. We predicted an organ to be
metabolically non-essential if a non-zero whole-body maintenance
reaction flux was possible in a WBM model deficient in that organ
attevraHyevraH
Reacons Metabolites Genes Reacons Metabolites Genes
Core 109 (1.4%) 211 (5.5%) 176 (10.5%) 109 (1.4%) 207 (5.4%) 171 (10.2%)
Organ-specific 1,097 (14.6%) 366 (9.6%) 20 (1.2%) 1,161 (15.3%) 382 (9.9%) 19 (1.1%)
Others 6,333 (84%) 3,249 (84.9%) 1,485 (88.3%) 6,334 (83.3%) 3,251 (84.7%) 1,491 (88.7%)
Total 7,539 3,826 1,681 7,604 3,817 1,681
B  Distribuon of reacons, metabolites, and genes across the  32 organs



































Frequency Frequency Frequency Frequency
Harvey
Harvea
Frequency Frequency Frequency Frequency
Figure 2. The organ compendium contains sex-specific metabolic reconstructions.
A Distribution of content in the male (blue) and female (pink) organ-specific reconstructions.
B Overall statistics of the organ compendium. Core reactions, genes, and metabolites refer to those that are shared between all organs in Harvetta or Harvey. The
category “other” refers to all reactions, genes, or metabolites that appear in more than two but < 30 (Harvetta) or 28 (Harvey) organs (Dataset EV2: 3.7).
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(Dataset EV2: 3.5). We defined an organ to be metabolically non-
essential in vivo if it can be surgically removed or replaced by an artifi-
cial organ (e.g., heart; Table EV15). Of the 32 organs, for 28 we could
find corresponding information and predicted the metabolic essential-
ity correctly in all but one case (Fig 4A). It is important to note that
the WBM models can only assess metabolic essentiality but do not
capture other essential organ functions (e.g., those of the brain).
To further assess the predictive capacity of the WBM models, we
simulated 57 inborn errors of metabolism (IEMs) by deleting the
corresponding reaction(s) in all organs having the known defective
gene(s) (Dataset EV2: 3.8, Materials and Methods, Statistical
analyses). We then predicted and compared for each IEM the known
biomarkers in either blood, urine, or CSF. Across the 57 IEMs, a
total of 215 out of 252 (85.3%) biofluid specific biomarkers were
qualitatively predicted correctly by Harvetta and 214 out of 252
(84.9%) by Harvey (Fig 4B, Table EV16). We compared this with
similar predictions using the Recon3D model, which has only one
extracellular compartment. As expected, the number of biomarkers
was smaller than could be predicted (205 metabolites). Notably, the
predictive potential of the Recon3D model was lower than that of
the WBM models, with only 103 biomarker metabolites predicted
correctly (50.2%, Fig 4B). Overall, the biomarker predictions with
Harvetta and Harvey showed higher agreement percentages,
increased Cohen’s kappa metrics, and significantly better agreement
percentages per disease (P = 0.0003 and P = 0.0001 for Harvetta
and Harvey, respectively; Fig 4B). The better prediction capabilities
of the WBM models were mainly caused by having fewer inconclu-
sive or unchanged predictions, meaning that those metabolites were
not predicted to be biomarkers. While for the Recon3D model,
45.3% (93 of 205) of the predictions failed to predict any changes,
only 7.1% (18 of 252) fell into this category for Harvetta and 8.7%
(22 of 252) for Harvey. Hence, the ability to account for physiologi-
cal and metabolic constraints as well as organ-level separation of
metabolic pathways enhanced the prediction capacity considerably
and presented a key advantage of using a WBM model over the
generic Recon3D model.
In the WBM models, we investigated the constraints sufficient
for the activity of two inter-organ metabolic cycles (Frayn, 2010),
when minimizing the Euclidean norm of the flux vector, with the
rate of the whole-body maintenance reaction set to one (Dataset
EV2: 3.3.2.2). In the Cori cycle, glucose is secreted by the liver and
taken up by the muscle, which produces lactate, which is then taken
up by the liver to produce glucose (Fig 4C). Elevated postprandial
blood glucose concentration, mediated by insulin levels, determines
the rate at which glucose is taken up in vivo (Wasserman et al,
2011), but the regulatory functions of insulin are beyond the scope
of the present WBM models. Consistently, only enforcing muscle
glucose uptake was sufficient to achieve activity of the Cori cycle in
the WBM models, at rest (Dataset EV2: 3.3.2.2). In the Cahill cycle,
glucose is secreted by the liver and taken up by the muscle, which
converts it to alanine, which is taken up by the liver to produce
glucose (Fig 4C). The Cahill cycle is increased during exercise,
when muscles degrade amino acids for energy needs, as a means to
remove ammonium from the body via urea production in the liver
(Frayn, 2010). Consistently, enforcing muscle glucose uptake, and
enforcing either liver alanine uptake or increasing urinary urea
excretion was sufficient to achieve activity of the Cahill cycle in the
WBM models (Dataset EV2: 3.3.2.2).
To demonstrate that the aforementioned results are a conse-
quence of including reactions and constraints based on organ-level
data, we then tested the degree of functional redundancy in the
WBM models. Therefore, we removed random subsets of reactions
and checking the feasibility of a unit flux through the whole-body
maintenance reaction. We found that there was an exponential drop
in the number of feasible models as the fraction of reactions
removed was increased (Appendix Fig S1B). Specifically, 60% of the
WBM models (600/1000) were feasible if 0.1% of reactions (81/
A Physiological parameters
Value/Range Unit
Weight M: 70, F: 58 kg
Height M: 170, F: 160 cm
Heart rate 67 beats/min
Stroke volume 80 ml/beat
Cardiac outputa 5,360 ml/min
Hematocrit 0.4 packed cell volume
CSF flow rate 0.35 ml/min
CSF to venous blood flow 
rate
0.52 ml/min 
Urine producon 2 l/day
Blood flow rate (at rest) 4.9 – 1,081 ml/min
Renal filtraon fracon 20 %
Glomerular filtraon rateb 90 ml/min
Creanine concentraon in 
urine
0.5–1.2 mg/dL
Oxygen uptake (VO2)c 19.080 mmol/day
Respiratory exchange rao 0.8
B Composion of the average 
European diet corresponding to 2,371.9 
kcal per day per person
a Heart rate*Stroke volume
b Blood flow fracon (Kidney)*CardiacOutput*(1-Hematocrit)








Figure 3. Combining metabolism with physiology enabled
physiologically constrained, stoichiometric modeling.
A List of physiological parameters used to constrain the reactions. The
physiological values were retrieved for a reference man and woman (Snyder
et al, 1975). A complete list of simulation constraints can be found in
Materials and Methods (Conversion from reconstruction to condition-
specific models) and Dataset EV2: 3.2.
B Nutritional composition of the average European diet.
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a Essenality was based on whether a surgical 
procedure removing the enre organ could be 
found.
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B – Blood, CSF, and urine biomarker predicons for inborn errors of metabolism
Recon3D* up unchanged down
up 85 84 7
















RECON3D* 50.24% 0.20(0.14;0.25) 1.333e-13 -
Harvea 85.32% 0.47(0.37;0.57) 4.056e-15 0.0003

























































Single reacon Pathway, only one reacon shown
Figure 4. Assessment of the predictive potential of the WBM model.
A Comparison of predicted and in vivo organ metabolic essentiality (Table EV15).
B Statistical agreement between in silico and in vivo predictions for reported biomarkers of 57 inborn errors of metabolism using the WBM models and a Recon3D
model (Table EV16).
C Cori and Cahill cycle fluxes involving liver and muscles (in mmol/day/person). Key reactions from a single flux distribution for the female WBM model, obtained by
minimizing the Euclidian norm, subject to mass-balance and physiological constraints. Only a subset of the active intra-organ pathways is shown; hence, the values
of influx and efflux to a metabolite are not equal in the figure. Please refer to Dataset EV2: 3.3.2.2 or vmh.life for reaction details.
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81,094) were randomly removed and none of the models was feasi-
ble when 1% of the reactions were randomly removed.
This reliable prediction of organ and gene essentiality, as well as
the feasibility of inter-organ metabolic cycles, and the infeasibility
of whole-body maintenance upon random reaction removal, demon-
strates that the topology of the WBM models is a specific and sensi-
tive representation of whole-body metabolism but that constraints
are required to enforce condition-dependent metabolic activity.
The whole-body metabolic models predict basal metabolic flux
and activity-induced energy expenditure
The basal metabolic rate (BMR) varies between individuals, depend-
ing on their age, sex, weight, height, and body composition.
Phenomenological methods (Harris & Benedict, 1918; Mifflin et al,
1990) have been developed for estimating BMRs, but they do not
account for differences in metabolism. Here, we investigated
whether the WBM models, which incorporate metabolism and phys-
iological constraints (Fig 3), could be used to predict BMRs with
higher accuracy than the phenomenological methods. To this end,
we assumed that BMR is equal to the energy yield from ATP hydrol-
ysis (64 kJ; Wackerhage et al, 1998) times the resting rate of steady-
state ATP consumption. The latter was predicted by setting the
whole-body maintenance reaction flux to one, minimizing the Eucli-
dean norm to obtain a unique steady-state basal metabolic flux
vector (Heirendt et al, 2019) and summing the rate of ATP
consumption of all reactions in all organs (Dataset EV2: 3.3). The
whole-body maintenance reaction represents the material and
energy (ATP) required to maintain the non-metabolic cellular func-
tions of the body and was constructed based on the fractional
weight contribution for each organ for a reference man or woman
(Snyder et al, 1975) (Dataset EV2: 3.2). In the basal metabolic flux
vector, ATP consumption by the whole-body maintenance reaction
is < 2% of the total ATP consumption. Without any fitting, or
accounting for age, we predicted overall energy consumption rates
of 1,344 kcal for Harvetta and 1,455 kcal for Harvey, which were
consistent with the expected values for a reference man and
woman, respectively.
Age, weight, and height from 13 healthy women with normal
body mass index (BMI < 22.1  2.4) (Prentice et al, 1986) (Fig 5A,
Dataset EV2: 3.9, Table EV17) were used, together with established
polynomial functions (Dataset EV2: 3.10.1.5; Young et al, 2009), to
fix the physiological parameters (organ weights, blood flow rate,
and cardiac output) of a set of personalized Harvetta models. We
then tuned Harvetta to fit corresponding personalized BMR
measurements by performing a sensitivity analysis (Dataset EV2:
3.9.1) thereby identifying parameters in Harvetta that could be
adjusted to fit the BMR data better. As the fat-free body mass was
provided for each individual, we adjusted the muscle and adipocyte
coefficients in the whole-body maintenance reactions, instead of
solely relying on the estimated values based on age, weight, and
height (Young et al, 2009). We also increased the ATP coefficient in
the muscle biomass maintenance reaction, starting from a previ-
ously estimated coefficient (Bordbar et al, 2011a), to better reflect
the energetic requirements associated with protein turnover in the
muscle. After optimizing the ATP coefficient, the WBM model was
able to predict the measured BMR with high accuracy (explained
variance = 79.7%, F(1, 11) = 43.14, P = 4.04e-05, Fig 5B) and
better than the Mifflin-St Jeor equations (Fig 5C). However, as
parameter tuning was involved, potentially leading to overfitting,
we validated the WBM BMR prediction models with an independent
data set not utilized in parameter estimation.
An independent, external data set, composed of age, weight,
height, fat-free body mass, and BMR data from six female and 16
male athletes (Loureiro et al, 2015) (Fig 5D) was used to assess the
ability of the previously tuned WBM models to predict BMR
(Dataset EV2: 3.9.2, Table EV17). Good correlation was obtained
between predicted and measured BMR (explained variance
= 61.3%, F(2, 19) = 15.06, P = 1.10e-4) (Fig 5E). In comparison,
the Mifflin-St Jeor equations, a standard phenomenological method
of estimating the BMR from age, sex, height, and weight (Mifflin
et al, 1990), gave a lower correlation (R2 = 0.49, P = 0.002)
(Fig 5F). Furthermore, given the WBM models, the Mifflin-St Jeor
equations were not informative for the true BMR (linear regression
b = 0.01, 95%-CI:(0.99, 1.00), P = 0.90). In contrast, the WBM
prediction added predictive value to the Mifflin-St Jeor equation (lin-
ear regression b = 2.24, 95%-CI: (0.32; 4.16), P = 0.025). The last
result implies that the WBM models are significantly superior to the
Mifflin-St Jeor equations in terms of prediction accuracy. Taken
together, the results demonstrate that the WBM models provide
good and replicable estimations of BMRs that improve on standard
phenomenological methods. However, the analyses also highlight
the need for personalized parameterization of the WBM models for
a given simulation and that the use of further parameters is likely to
improve the prediction fit. Equally, confounding factors, beyond age
and sex, should be considered and validation in a larger cohort will
be required.
Beyond the basal metabolic rate, activity-induced energy expen-
diture consumes the remaining energy and nutrient resources
provided by the diet (Biesalski & Grimm, 2005). With the afore-
mentioned basal metabolic flux distribution (Dataset EV2: 3.3.2.3),
the resting brain energy consumption rate was initially predicted
to be 10.5 mole ATP/female/day (Dataset EV2: 3.3.2.3). Assuming
a conversion of 1 mole of glucose into 31 moles of ATP, this value
is lower than a total brain consumption rate of 20.65 mole ATP/
day/person, based on the reported consumption rate of 120 g of
glucose per day (Berg et al, 2002). To achieve a 20 mole ATP/
female/day total brain consumption rate, we had to set a require-
ment for the brain to hydrolyze 3.5 mole ATP/female/day for elec-
trophysiological processes (VMH ID: Brain_DM_atp_c_). Note that
this demand for hydrolysis of ATP requires further hydrolysis of
ATP by supporting metabolic pathways elsewhere in the brain.
Similarly, the pumping of blood through the body by the heart
requires the hydrolysis of ATP. However, literature reports differ
in their estimated energy requirements with one source reporting
6,000 g ATP/day/person to be consumed (https://heartmdinsti
tute.com/heart-health/metabolic-cardiology-basics/), which corre-
sponds to 11.8 mole ATP/day/person with the molecular weight
of ATP being 507.18 g/mole (Dataset EV2: 3.2.2.7). A lower
bound on a heart demand for hydrolysis of ATP (VMH ID: Heart_
DM_atp_c_) was set to 6 mole ATP/day/person to account for the
energy required for pumping blood through the body while allow-
ing the remained to be consumed by supporting heart metabolic
reactions. Despite the lack of comparable measurements of activ-
ity-induced ATP consumption rates, we set these parameters on
brain and heart ATP hydrolysis because each organ contributes to
8 of 24 Molecular Systems Biology 16: e8982 | 2020 ª 2020 The Authors
Molecular Systems Biology Ines Thiele et al
Mean (Standard deviaon)
Females (n=13)
Age (years) 29 (±5)
Height (cm) 161 (±8)
Weight (kg) 57.5 (±6.3)
BMI 22.1 (±2.4)
Fat-free body mass (kg) 41.3 (±23.9)
Measured BMR (kcal) 1,350.4 (±31.1)
Mean (Standard deviaon)
Females (n = 6) Males (n = 16)
Age (years) 14.7 (±2.7) 14.8 (±1.7)
Height (cm) 159.3 (±9.9) 169.3 (±8.5)
Weight (kg) 50.5 (±8.9) 57.3 (±8.6)
BMI 19.7 (±1.5) 19.9 (±1.5)
Fat-free body mass (kg) 39.15 (±9.6) 48.6 (±7.8)
Measured BMR (kcal) 1,353.7 (±143.3) 1,564.2 (±208.3)
Training data
WBM based predicon of BMRs
Phenomenological method based 
esmaon of BMRs
Independent, external tesng data
WBM based predicon of BMRs
Phenomenological method based 
esmaon of BMRs
Overview of the data set Overview of the data setA D
B E
C F
Figure 5. Application of the WBM models to predict basal metabolic rates (BMRs).
A-C A training data set (Prentice et al, 1986) was used to identify parameters to improve the prediction of the BMRs (A). Therefore, the WBM models were first
constrained based on age, height, and weight (Dataset EV2: 3.9, Table EV17). We then adjusted fat-free mass and the ATP requirements in the muscle, to obtain a
better fit of the predicted and measured BMRs (B). For comparison, we estimated the BMRs using a phenomenological method, being the Mifflin-St. Jeor equations,
and compared the estimates with the measurements (C).
D–F Subsequently, we validated the identified tuning parameters, being adjusted fat-free mass and the ATP requirements in the muscle, using an independent, external
data set (D) (Loureiro et al, 2015). The WBM model based predicted BMRs for the independent data set (E) outperformed the phenomenological method (F).
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the overall energy consumption in a whole-body model. After
accounting for whole-body maintenance and energy demand due
to brain and heart activity, the basal metabolic flux distribution
predicted that the remaining energy that the WBM models could
extract from the dietary input was 515.7 kcal for Harvetta and
502.5 kcal for Harvey. These values correspond to approximately
20% of the average European dietary input (2,372 kcal) used for
the WBM simulations. This result is consistent with a 15–30%
allocation of dietary input toward physical activity (Biesalski &
Grimm, 2005).
Overall, we demonstrated that WBM model predictions of basal
metabolism and energy requirements are overall consistent with the
literature and they provide an opportunity for integration of both
physiological and molecular biological data to enable enhanced
predictions when compared with purely phenomenological
methods.
Personalized microbiome-associated WBM models to simulate
gut–organ co-metabolism
The human gut microbiota influences host organ metabolism,
including the brain (“gut-brain axis”), the liver (“gut-liver-axis”),
and the colon (Clarke et al, 2014). However, our understanding of
host–microbiome co-metabolism remains limited. The WBM models
can be used to predict how the microbiome may modulate human
metabolism, thereby complementing existing in vitro and in vivo
analysis approaches.
To constrain Harvetta and Harvey in a gut microbial context, we
used published shotgun metagenomics and clinical data on 149
healthy individuals provided by the Human Microbiome Project
(HMP) Consortium (Consortium, 2012a; Peterson et al, 2009)
(Dataset EV2: 3.10, Fig 6A). First, we generated personalized germ-
free WBM models using clinical data on sex, weight, height, and
heart rate of each individual. Second, we mapped the reported
strain-level abundances for each individual onto a resource of 773
gut microbial metabolic reconstructions (Magnusdottir et al, 2017;
Dataset EV2: 3.10.1). The resulting 149 personalized microbial
community models captured 131  19 microbes per HMP individ-
ual, accounting for 91  7% of the reported relative abundance
(Appendix Fig S2). Third, the microbial community models were
added to the large-intestinal lumen of the corresponding personal-
ized WBM models, resulting in personalized microbiome-associated
(my) WBM models. In the large-intestinal lumen of these personal-
ized myWBM models, gut microbes can take up dietary metabolites
after they transit from the small intestinal lumen where small
intestinal enterocytes may also absorb them. Metabolites produced
by gut microbes can be taken up by colonocytes or excreted via the
feces.
The human gut microbiome is a source of amino acids and
neuroactive compounds (Clarke et al, 2014; Lin et al, 2017). Hence,
we investigated whether the presence of the gut microbiota in
personalized myWBM models could increase the maximal possible
production rate of eight prominent neurotransmitters. We first maxi-
mized the neurotransmitter production in the brain in the personal-
ized germ-free WBM models and observed substantial inter-
individual variation (Fig 6B). This variation could be attributed to
the changed bounds on the organ uptake reactions due to the person-
alization of the physiological parameters. We then used the
personalized myWBM and observed substantial increase in the
brain neurotransmitter production capability. No clear correlations
between brain neurotransmitter synthesis potential and individual
microbial species were observed (Fig 6C). The high inter-individual
variation in these metabolic objectives could neither be explained
by the presence of a single species or genus (Fig 6B and C) nor by
the provided meta-data. Consequently, we hypothesized that the
simulation results were the direct consequence of the host–gut
microbial co-metabolism and could not be derived from the metage-
nomic data alone. Using the 149 personalized microbiome models
without the WBM, we calculated the neurotransmitters and neuro-
transmitter precursors predicted to be secreted by each strain
(Appendix Fig S3). For instance, GABA was predicted to be
produced by Akkermansia muciniphila and strains of the Bacter-
oides, Escherichia, and Shigella genera. Consistently, GABA-produ-
cing capability has been shown for Bacteroides, Parabacteroides,
and Escherichia species (Strandwitz et al, 2019). Glutamate, the
precursor of GABA and itself a neurotransmitter, was predicted to
be mainly produced by Eubacterium rectale, Faecalibacterium, Rose-
buria, and Bacteroides. Histamine was predicted to be produced
mainly by Gammaproteobacteria species and Streptococcus sp., in
agreement with reports that members of these taxa synthesize hista-
mine (Clarke et al, 2014). Histidine, the precursor of histamine, was
predicted to be produced mainly by commensals of the Bifidobac-
terium genus and of the Clostridiales order (e.g., Faecalibacterium,
Roseburia). Alistipes and Bacteroides sp. were predicted to produce
the majority of L-tryptophan, a precursor of serotonin. Finally, L-
tyrosine, a precursor of dopamine, was predicted to be produced by
a variety of species belonging to the Actinobacteria, Firmicutes, and
Proteobacteria phyla. Taken together, the modeling results predicted
that gut microbes have the molecular mechanisms that may influ-
ence host brain metabolism directly by synthesizing neurotransmit-
ters and indirectly by providing the amino acid precursors to be
further metabolized by human enzymes. The predicted maximum
secretion potential, as well as the contributing strains, depended on
each individual’s microbiome composition. Thus, the WBM models
can be used to generate novel mechanistic hypothesis as to how the
gut microbiota might influence brain metabolism (Clarke et al,
2014; Lin et al, 2017).
Ethanol causes liver toxicity as its product, acetaldehyde, is cyto-
toxic and carcinogenic (Neuman et al, 2017). When maximizing the
flux through the liver alcohol dehydrogenase (VMH ID: ALCD2if),
the myWBM models predict an 11.4  8.5 fold increase in maximal
potential flux compared with corresponding personalized germ-free
WBM models (Fig 6E). This fold change in flux strongly correlated
with species belonging to the Clostridia class and negatively corre-
lated with representatives of the Bacteroidia class (Fig 6E). Conse-
quently, the Bacteroidia/Clostridia ratio determined 92.1% of the
variation in the predicted maximum alcohol dehydrogenase flux
(F(2, 144) = 852.21, P = 1.56e-80, see Table EV18). Species that
affected the most the alcohol dehydrogenase flux included Clostrid-
ium scindens, Blautia hydrogenotrophica, and the well-known
pathobiont Clostridium difficile (Fig 6C). Endogenous ethanol
production by the microbiota has been shown in non-alcoholic
steatohepatitis (NASH) patients (Zhu et al, 2013). Further support
that microbial endogenous ethanol production can perturb liver
function and cause non-alcoholic fatty liver disease has been
recently published (Yuan et al, 2019).
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Microbially produced butyrate serves as the main energy source
for the colonocyte (Donohoe et al, 2011). We computed the maxi-
mum flux through the butyrate-CoA ligase in the colonocytes in the
personalized myWBM models. The predicted maximum butyrate-
CoA ligase flux was on average 78.7  64.7-fold increased in the
presence of the microbiome (Fig 6F) and strongly correlated with
the abundance of known butyrate producers, such as Faecalibac-
terium prausnitzii, Butyrivibrio crossotus, and Subdoligranulum vari-
abile (Louis & Flint, 2009). The Bacteroidia/Clostridia ratio
determined 92.9% of the variance in the predicted maximum buty-
rate-CoA ligase flux (F(2, 144) = 953.32, P = 8.8e-84, Table EV18).
Consistently, it is known that butyrate is mainly produced by
microbes belonging to the Clostridia class (Louis & Flint, 2009).
The human gut microbiota can also influence drug metabolism
(Spanogiannopoulos et al, 2016). Flux balance analysis was used to
predict the maximal possible flux through the liver sulphotrans-
ferase reaction (VMH ID: PCSF) in each myWBM model (Fig 6D).
myWBM models with low Clostridioides genus abundance were
predicted to have lower maximum liver sulfonation flux (Fig 6D).
The potential for liver sulfonation was inversely correlated with the
abundance of the Bacteroidia class (Fig 6D), such that the Bacter-
oidia/Clostridia ratio contributed 53.6% of variance to maximal
A Characteriscs of the microbiome-
associated WBM models
Feature Male (n=83) Female (n=66)
Weight (kg) 80.3 11.3 65.5 13.1
Height (cm) 178.6 7.1 163.1 6.6
Age (years) 27.0 5.0 25.9 5.0
Heart rate (beats/min) 71.6 11.6 75.3 11.1













E Liver alcohol 
dehydrogenase
C Species abundance correlaon
D Liver 
sulphotransferase
F Colon carboxylic 
acid:CoA ligase





R2=0.92, p<0.001 R2=0.93, p<0.001
Figure 6. Application of the 149 personalized microbiome-associated (my) WBM models to predict host–microbiome co-metabolism.
A Characteristics of the myWBM models.
B Average brain biosynthesis potential for eight neurotransmitters in the personalized WBM models displayed as the difference between with and without
microbiome (germ-free). P-values from paired t-tests.
C Spearman correlations between species-level abundances and fold changes in fluxes (microbiome-associated vs. germ-free) for flux through 11 objective functions.
Each data point is the Spearman correlation between 149 changes in fluxes for one reaction and 149 abundances for one species.
D–F Bacteroidia/Clostridia ratio against maximal flux (mmol/day/person) against (relative abundance) through the different reactions. Regression line from fractional
polynomial regression and p-values from likelihood ratio tests. Inlet: Average maximal reaction flux in microbiome-associated and germ-free WBM models.
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liver sulfonation rates (F(2, 144) = 85.37, P = 3.547e-25,
Table EV18). Note that, at higher Clostridioides genus abundances,
substrate availability was limiting for p-cresol production and subse-
quent sulfonation (Appendix Fig S4). Overall, consistent with our
results, it is known that the production of p-cresol, e.g., by Clostrid-
ium difficile, competes with drugs, such as acetaminophen, for
sulfonation in the liver and interferes with drug detoxification
(Spanogiannopoulos et al, 2016).
Taken together, using the personalized myWBM models, we
demonstrate that this modeling framework can generate predictions
of how microbial metabolism may modulate host metabolism.
Importantly, some of these predictions have already been shown
experimentally to be consistent with known host–microbe co-meta-
bolism. Thus, the myWBMs are suitable for the generation of novel,
experimentally testable hypotheses on host-microbe co-metabolism,
the development of microbe-modulated biomarkers, and for the
identification of individuals with increased risk of toxicity.
Discussion
We presented two sex-specific, organ-resolved, molecular-level,
anatomically and physiologically consistent reconstructions of
human whole-body metabolism. The underlying reconstruction of
human metabolic pathways (Brunk et al, 2018) has been devel-
oped over the past decade based on over 2,000 literature articles
and books, and provided an indispensable foundation for the
WBM reconstructions. Organ-specific metabolism (Figs 1 and 2)
was based on more than 600 published studies and books, and
accounts for comprehensive proteomic and metabolomics data.
Known inter-organ metabolic interactions, as illustrated with the
classical examples of the Cori and the Cahill cycles, as well as
organ-essentiality and inborn errors of metabolism (Fig 4) were
captured with the WBM reconstructions, as were whole-body func-
tions, such as BMR and the energy use (Fig 5). Using the micro-
biome-associated WBM models, we could show that individual
microbes, or microbial communities, may be used to explore their
potential influences on the metabolism of different host organs
(Fig 6). Importantly, for some of these predictions, we could find
supporting evidence in the literature that such host–microbe co-
metabolism does indeed occur. Finally, the personalized WBM
models reflected inter-individual variability in metabolism due to
varied physiological parameters, which were broadly consistent
with phenomenological observations. Taken together, the WBM
reconstructions represent a molecular-level description of organ-
specific processes built on current knowledge and underpinned by
basic physicochemical principles.
The creation of organ-specific metabolic reconstructions is chal-
lenging despite the myriad of omics data and sophisticated algo-
rithms (Opdam et al, 2017). We tackled this challenge with an
iterative approach combining extensive literature review, omics
data, and high-performance computing (Fig 1). Moreover, the inclu-
sion of biofluid compartments in the WBM reconstructions enabled
the integration of quantitative metabolomics data, while the use of
microbiome information and dietary information increased the
comprehensiveness of the WBM reconstructions. The interlinked
metabolic complexity captured in the WBM reconstructions could
not have been achieved by using an organ-by-organ reconstruction
approach, as such an approach would not consider the inherent
cooperation between the body’s organs. Importantly, this novel
whole-body reconstruction paradigm may present a blueprint for
other multi-cellular model organisms, such as the virtual physiologi-
cal rat (Beard et al, 2012).
In addition to our genome and diet, our (gut) microbiome contri-
butes to inter-individual variation in disease development and
progression (Sonnenburg & Backhed, 2016). Computational models
aimed at accounting for these factors have been, in part, hampered
by the lack of a molecular-level, organ-resolved description of
human metabolism. While the gut microbiota can modulate human
metabolism on an organ level (Zhu et al, 2013; Yuan et al, 2019),
the underlying pathways are typically elucidated using animal
models (Claus et al, 2008; Sampson et al, 2016; Virtue et al, 2019).
The WBM models, when associated with microbiomes, enable such
analysis in silico and a comparison with their germ-free counterpart.
This capability facilitates the formulation of novel, mechanistic
hypotheses on how gut microbes, individually and collectively, may
modulate human metabolism, and vice versa. While these hypothe-
ses require experimental validation, the WBM models permit priori-
tization of experimental studies, thus accelerating knowledge
creation through a systems biology approach.
One may question whether it is enough to use the germ-free
WBM models, considering the impact of the microbiome on human
metabolism, as also illustrated with our examples (Fig 6). We
argue that using the germ-free WBM models without the gut micro-
biome is valuable and valid, as we applied measured blood
metabolite concentration ranges as constraints for each organ.
These metabolite concentration ranges have been obtained from,
e.g., the Human Metabolome Database (Wishart et al, 2013). These
ranges are assumed to represent the concerted metabolic activity
of host and microbial metabolism. Nonetheless, we believe that
the inclusion of the microbiome adds another dimension to the
possible applications of the WBM models. While, in this study, we
only demonstrated the inclusion of the human gut microbiome,
microbiomes from other body sites (Costello et al, 2009; Consor-
tium THMP, 2012a; Pasolli et al, 2019), such as the small intestine,
the vagina, the skin, or the oral cavities, should eventually be also
considered.
The WBM reconstructions represent anatomically consistent
topological connections between organs. Current approaches have
either assumed a whole-body human metabolic network without
organ boundaries (Aurich & Thiele, 2016; Nilsson et al, 2017) or
simplified it (Bordbar et al, 2011a), which ultimately limits its
general usability and predictive capacity. Here, in contrast, we
considered individual-level physiological, nutritional, and microbial
parameters for personalization of the WBM models and provide a
novel tool to study inter-individual variability in physiological
processes as well as drug metabolism (Thiele et al, 2017). Multi-
omic data for healthy and diseased individuals are becoming
increasingly available (Price et al, 2017), requiring novel tools for
the integrative analysis of such diverse data. The omics data also
provide a unique opportunity to further constrain and personalize
the WBM models. Such personalization of computational human
models is also a requirement for enabling in silico clinical trials
(Viceconti et al, 2016).
The presented WBM reconstructions describe the metabolism of
a large number of organs in the human body but are not yet
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resolved to the tissue or cellular level. For instance, the kidney and
the liver are anatomically complex organs, consisting of many
different cell types with distinct metabolic functions. The WBM
reconstructions will need to be expanded to include cell-specific
metabolism within the individual organs, which will be enabled
through advances in single-cell omics technologies (Han et al,
2018). Another limitation is that our WBM reconstructions capture
only metabolism, ignoring important processes, such as signal trans-
duction and regulation, immune response, and the action of
hormones. For some of these processes, computational models have
been already constructed (Chelliah et al, 2015). Using metabolic
models as a framework for integration of other types of models has
been already demonstrated, most notably in a model of Mycoplasma
genitalium (Karr et al, 2012).
This new physiologically and stoichiometrically constrained
modeling (PSCM) approach allows the integration of physiological
parameters and quantitative metabolomics data to restrict organ
uptake rates to physiologically relevant values and thereby limit the
achievable intra-organ metabolic flux states. Our computational
approach is tractable, as it relies either on solutions to linear or
quadratic optimization problems. In contrast, hybrid modeling
approaches, such as the ones integrating physiology-based pharma-
cokinetic modeling with genome-scale models (Eissing et al, 2011;
Krauss et al, 2012; Guebila & Thiele, 2016), require a flux solution
for a metabolic submodel at each time step. All processes in the
human body are intrinsically dynamic, but many whole-body meta-
bolic questions can be addressed while assuming a steady state. In
those cases, WBM modeling is a valuable, time-efficient alternative
to hybrid modeling as it represents human metabolism at a more
comprehensive level, and yet it is computationally tractable.
Taken together, the WBM reconstructions and personalizable,
versatile models of Harvetta and Harvey represent a significant step




In this part, we describe the reconstruction approach and the infor-
mation used to generate the WBM reconstructions, Harvey and
Harvetta. The conversion of the reconstructions into condition-
specific WBM metabolic models is then described Statistical
analyses details can be found at the end of the Materials and
Methods section. Simulation-relevant information and methods can
be found in the Dataset EV2 (or here: https://opencobra.github.io/
cobratoolbox/stable/).
The human metabolic reconstruction served as a starting point for
the WBM reconstructions
As a starting point for the WBM reconstructions, we used the global
human metabolic reconstruction, Recon3D (Brunk et al, 2018),
which accounts comprehensively for transport and biochemical
transformation reactions, known to occur in at least one cell type.
Recon3D was assembled based on more than 2,000 literature
sources. Recon3D was obtained from the Virtual Metabolic Human
database (https://www.vmh.life/#downloadview, version 3.01). In
Recon3D, many of the enzyme-catalyzed reactions or transport reac-
tions are associated with the corresponding gene(s) that encode
the protein(s). These so-called gene-protein-reaction associations
Table 2. Biofluid compartments and the connected organs present in
the WBM reconstructions.
Biofluid
compartment Abbreviation Connected organs
Diet [d] –
Lumen [lu] –
Lumen, small intestine [luSI] Small intestinal cells
Lumen, large intestine [luLI] Colonocytes
Feces [fe] –
Blood, circulation [bc] All except brain and
spinal cord
Blood, portal vein [bp] Liver, colonocytes, small
intestinal cells, pancreas,
spleen
Bile duct [bd] Liver, gallbladder







Figure 7. Biofluid compartment definitions for the individual organs in
the WBM reconstructions.
Refer to Table 2 for the abbreviations of the biofluid compartments.
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(GPRs) are represented through Boolean rules (“AND”, “OR”) for
isozymes or protein complexes, respectively. The reconstruction of
Recon3D consists of 13,543 reactions, 4,140 unique metabolites,
and 3,288 genes. The Recon3D publication also contained a flux and
stoichiometrically consistent global metabolic model (Recon3D
model) accounting for 10,600 reactions, 5,835 non-unique metabo-
lites (2,797 unique metabolites), and 1,882 unique genes. Hence, we
used the Recon3D model, rather than Recon3D as starting point, as
we wished the WBM reconstructions, and their derived models to
be also flux and stoichiometrically consistent. From the Recon3D
model, we removed from all reactions, and metabolites, involved in
protein and drug metabolism, as these pathways were beyond the
anticipated scope of the first version of the WBM reconstructions.
We then removed flux inconsistent reactions (i.e., those reactions
that did not admit non-zero net flux) using the COBRA toolbox
(Heirendt et al, 2019). The resulting metabolic flux and stoichiomet-
rically consistent model, named Recon3D*, contained 8,418 reac-
tions, 4,489 (non-unique) metabolites, 2,053 transcripts, and 1,709
genes, and was used in the following to assemble the WBM recon-
structions.
Setup of the multi-organ, sex-specific meta-reconstructions
The central idea of the novel reconstruction paradigm was to gener-
ate sex-specific, organ-resolved WBM reconstructions that were not
built by connecting the separate organ-specific metabolic recon-
structions but which would emerge as one functional, self-consistent
whole-body metabolic system from the metabolic capabilities and
known interactions between the organs.
Preparation of the organ-specific metabolic reconstructions to be
included in the meta-reconstructions
We considered 20 organs, six sex-specific organs, and six blood
cells (Table 1). For simplicity, we refer to all of these as organs in
the following. We defined 13 biofluid compartments to be consid-
ered in the WBM reconstructions (Fig 1B, Table 2). For each
organ, transport reactions from the extracellular compartment ([e])
to the blood compartment ([bc]) were added to Recon3D*. An
example of such transport reactions is the transport of metabolite
A from and to the blood compartment into the extra-organ space
of the heart: Heart_EX_A[bc]_[e]: 1 A[bc] <=> 1 Heart_A[e]. Addi-
tional transport reactions were added to those organs that are
connected to a third, or forth, biofluid (e.g., liver, Fig 7, Table 2).
For organs, which can only take up from or secrete into a particu-
lar biofluid (see arrows in Figs 1B and 7), the reaction directional-
ity was set accordingly. The corresponding transport mechanism
was always set to occur through facilitated transport, which
assumes that the metabolites can be transported from the biofluid
to the interstitial fluid surrounding the organ cells and that the
transport is driven either by concentration difference (diffusion) or
pressure difference (bulk flow). Each reaction in Recon3D* and the
newly added transport reactions received a suffix corresponding to
one organ (Table 1). Numerous organs are known to store metabo-
lites, e.g., the liver. We included sink reactions for stored metabo-
lites in the corresponding organs (Table EV6).
The male meta-reconstruction was constructed such that it
contained 28 times Recon3D* in an anatomically correct manner as
described in the next section (Fig 1B). The female meta-reconstruc-
tion was constructed such that it contained 30 times Recon3D* in
an anatomically correct manner. Each draft meta-reconstruction
contained more than 300,000 reactions.
Anatomically accurate organ connectivity
The dietary input compartment represents the exchange medium
consisting of all the dietary ingredients that the human body can
consume. We added diet uptake reactions for all metabolites with
defined exchange reactions in Recon3D*, as well as transport
reactions along the gastrointestinal tract (Fig 1B, Table 2) to the
draft meta-reconstructions. The dietary inputs from the [d] enter
the gastrointestinal lumen represented by [lu] in the WBM recon-
structions (Table 2). The lumen compartment setup in the model
represents the gastrointestinal lumen, which is unidirectional and
exits into the fecal excretion compartment [fe]. The fecal excretion
compartment represents the excretory end-products comprising
the undigested and unabsorbed part of the dietary input. In the
WBM reconstructions, the gastrointestinal lumen compartment is
further divided into the small intestinal lumen [luSI] and the
large-intestinal lumen [luLI]. While the gastrointestinal lumen
receives the diet input [d], the small intestinal lumen receives
metabolite drainage from the gallbladder (via the bile duct [bd]),
pancreas, and the small intestine. The large intestinal lumen is
specific for the large intestine receiving metabolites only from the
colonocytes and from the small intestinal lumen. Both small
intestinal epithelial cells (sIEC) and colonocytes were allowed to
take up metabolites from their corresponding luminal compart-
ment and could secrete some metabolites into the lumen (Tables
EV12A and EV13A). Gut microbes are known to produce in the
gastrointestinal tract valuable metabolic precursors to the human
host. To enable the uptake of such metabolites by the small
intestinal cells and the colonocytes, we added corresponding sink
reactions into the corresponding luminal compartments of the
meta-reconstructions (Table EV11).
The portal venous blood [bp] receives metabolites from the
colon, small intestine, spleen, pancreas, and gallbladder, which
drains into the liver for further metabolism and for exposure to the
systemic blood circulation [bc]. The bile duct [bd] is a special
compartment, which is specific for liver and gallbladder. Bile is
synthesized in the liver and stored in the gallbladder (Murray et al,
2000). From the liver, bile flows into the bile duct. The flow of bile
into the small intestinal lumen via the bile duct depends on the
Sphincter of Oddi that closes during the inter-digestive period,
increasing the pressure in the bile duct, and resulting in backflow of
bile into the gallbladder, where it is further concentrated. During the
digestive phase, the Sphincter of Oddi opens causing the concen-
trated bile flow into the small intestinal lumen to aid in digestion
(Gropper et al, 2009).
The systemic blood circulation [bc] is represented by the circula-
tory blood in the WBM reconstruction, which provides nutrients to
all organs. Since the brain and the spinal cord are specific in its
metabolite exchange, we introduced the blood–brain barrier and
cerebrospinal fluid [csf] as an additional compartment. The blood–
brain barrier selectively allows the exchange of metabolites, to and
from the brain (explained below), and the cerebrospinal fluid
receives metabolites from the brain, finally draining into the circula-
tory blood compartment (Fig 1). The lung takes up oxygen from the
environment and gives out carbon dioxide, which is captured as [a]
in the WBM reconstructions. Finally, the urine compartment [u]
14 of 24 Molecular Systems Biology 16: e8982 | 2020 ª 2020 The Authors
Molecular Systems Biology Ines Thiele et al
contains filtered metabolites from the kidney for final excretion.
These biofluid compartments signify precise anatomical barriers of
the organs of the human body.
To ensure that metabolites found in different biofluids based on
metabolomics data (see below) would also be present in the WBM
reconstructions, we added demand reactions for all those metabo-
lites to the corresponding biofluid compartments of the draft meta-
reconstructions. By doing so, we enforced that at least one organ
could produce a given metabolite, or that it would be taken up from
the diet (and the lumen).
Manual curation of the WBM reconstruction content
We defined a core reaction set containing all reactions, which
should be present in the WBM reconstructions based on literature
and omics data evidence. For each organ, the core reaction set was
expanded to include organ-specific (i) protein information from the
human proteome map (HPM) (Kim et al, 2014) and the human
protein atlas (HPA) (Uhlen et al, 2015), (ii) extensive manual cura-
tion of more than 600 literature sources for the presence or absence
of metabolic and transport reactions, genes, or pathways in all
organs, and (iii) reactions presence in four published tissue-specific
organs, i.e., red blood cell (Bordbar et al, 2011b), adipocyte (Bord-
bar et al, 2011a), small intestine (Sahoo & Thiele, 2013), and liver
(Gille et al, 2010). Note that these input data were not sex-specific,
due to the absence of corresponding data on an organ-specific scale.
This manual curation yielded a comprehensive core reaction
set, which served as input for the extraction algorithm (see section
1.3). For reactions that were found to be absent in an organ, we
set the corresponding lower and upper bounds to 0 in the draft
meta-reconstructions, which corresponds to removing them from
the meta-reconstructions. These absent reactions were then
removed from the meta-reconstructions by the algorithm as they
were not flux-consistent.
Proteomic data
The HPM resource (Kim et al, 2014) provides protein information
for 17,294 genes that accounted for 84% of the protein-encoded part
of the human genome. These proteins were obtained from normal
histological tissue samples, accounting for 17 adult tissue types and
6 primary hematopoietic cells, from three deceased individuals. We
queried the database (10/12/2015) for all genes present in
Recon3D*. For 1601/1709 Recon3D* genes/proteins (94% cover-
age) to obtain their distributions in the 23 tissue/cell types. The
protein expression data were scaled to range from 0 to 1. Only those
proteins with an expression level of greater or equal to 0.2 were
assumed to be expressed in an organ (Table EV2).
Moreover, to complement the HPM resource, we used HPA
(Uhlen et al, 2015). The protein expression data for the normal
tissues were downloaded and sorted according to the tissue type.
The proteins in the human protein atlas have been analyzed with a
single antibody, and the expression levels have been reported based
on the antibody staining (Uhlen et al, 2010). The expression levels
depend on the quality of the antibody used (Uhlen et al, 2010).
Hence, we considered only those proteins, which had a high and
medium expression level for a given tissue/organ. For the brain, we
combined the protein information of cerebellum, cerebral cortex,
hippocampus, and lateral ventricle. The Ensembl gene IDs were
converted to their corresponding EntrezGene IDs using the BioMart
tool from Ensembl (Flicek et al, 2014). Overall, HPA provided
protein expression information for 1504/1709 (88%) of the
Recon3D* genes (Table EV3). Together, these two proteomic
resources provided expression information for 1690/1709 (99%) of
the Recon3D* genes.
We used the GPR associations given in Recon3D* to identify
reactions to be present in the core reaction set. Note that in the case
of protein complexes, the presence of one of the proteins from the
complex was deemed sufficient to require the presence of at least
one reaction in the WBM reconstruction.
Literature-based curation of WBM reconstruction content
Organ-specific metabolic information We performed manual cura-
tion of reactions, genes, and pathways based on literature for all
included organs (Table EV1) but focused in particular depth on the
metabolism occurring in eight organs (skeletal muscle, skin, spleen,
kidney, lung, retina, heart, and brain), which contribute substan-
tially to inter-organ metabolism (Murray et al, 2009). We followed
the bottom-up, manual reconstruction approach established for
metabolic reconstructions (Thiele & Palsson, 2010).
To facilitate this large-scale, manual literature curation effort, we
defined “metabolic units” that not only accounted for the Recon3D*
sub-systems but were also metabolite specific. We categorized indi-
vidual metabolic and transport reactions in Recon3D* as metabolic
units. Each metabolic unit represented the first and last reaction step
of a particular pathway and contained three components: (i) major
metabolic pathway, (ii) product formed, and (iii) cellular location.
The reaction content of Recon3D* was classified into 427 metabolic
units when only the major metabolic pathway was considered, and
the cellular compartments ignored. When the whole metabolic unit,
along with all its components, was taken into account, 5,637 meta-
bolic units resulted. Usage of the metabolic units greatly accelerated
the reconstruction process as they account for individual metabo-
lite-specific pathways as well as key enzymes of the biochemical
pathways, in the same way that they are frequently reported and
referred to in the biochemical literature. This literature information
was translated into the occurrence and non-occurrence of metabolic
units. Additionally, we noted tasks that an organ can carry out (e.g.,
storage of glycogen) or the inability to carry out a particular task
(e.g., storage of vitamins occurs only in a limited number of
organs), leading to the formulation of organ-specific metabolic
objectives.
We also collected information on the pathways/reactions that
are absent across organs (Table EV1). Primary literature articles,
review articles, and books on organ-specific metabolism were thor-
oughly studied to derive the pathway information. In the case of
reported absence in an organ, the corresponding organ-specific reac-
tions were set to have a lower and upper bound of 0 in the meta-
reconstruction(s), thus effectively removing these reactions from the
organ.
Brief descriptions of the organ-specific metabolism for those
organs that we curated extensively for their metabolic content can
be found at the Virtual Metabolic Human database (www.vmh.life).
Presence of cellular organelles in organs Within the blood tissues,
differences in the presence of cellular organelles exist between fully
matured red blood cells and others. For instance, fully matured red
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blood cells are devoid of a nucleus and any other organelles (Berg
et al, 2001). The other hematopoietic cells, such as the B-lympho-
cytes, T-lymphocytes, natural killer cells, and monocytes, contain
all the cellular organelles (Takahashi et al, 1986; Kaneda et al,
1991; Delva et al, 2006). Therefore, we performed a thorough
manual search and obtained a definitive occurrence of cellular orga-
nelles for 19/32 organs from the literature (Table EV4). This search
was important to accurately represent the organs’ metabolic capabil-
ities in the WBM reconstructions. For the remaining organs, no
information could be found in the literature and the presence of all
organelles was assumed.
Nutrient storage within organs Maintenance of certain metabolite
pools and metabolite storage as a reserve for energy demands
within the cells is crucial for maintaining organ-specific functions.
For instance, glycogen is stored in liver and in the skeletal muscle
(Murray et al, 2000), and fatty acids are stored in the adipocytes
(Summers et al, 2000). During periods of fasting, liver glycogen
serves to maintain the blood glucose levels. Additionally, triglyc-
eride stores in the adipocytes are broken down to supply fatty acids
to skeletal muscle and heart to serve as an energy resource (Lan-
ham-New et al, 2013). A thorough manual search of the storage
capacity for metabolites and dietary nutrients by various organs was
performed. Known storage capacities were represented by adding
specific demand/sink reactions (Table EV6) to the corresponding
organs, which were then added to the core reaction set. The demand
reactions serve as cellular demand, or usage, of the metabolites in
the feeding stage and can be opened or closed when setting up the
simulation conditions (Dataset EV2). Similarly, the sink reactions
can release stored metabolites from the respective organs during
nutrient deprivation or overnight fasting state.
Metabolic objectives for organs As a result of the literature search
for the organ-specific metabolic pathways, we described each organ
by its chief metabolic functions, e.g., arginine synthesis by the
kidney, citrulline synthesis by the small intestine, cholesterol
synthesis by the spleen, vitamin D synthesis by the skin, and the
Cori cycle between liver and skeletal muscle. Glucose from liver
enters skeletal muscle, where it is converted to lactate via anaerobic
glycolysis. The muscle then releases lactate back into the circulation
to be utilized for gluconeogenesis by the liver, contributing to the
muscle-liver-Cori cycle (Murray et al, 2000). The kidney is the
major organ for the synthesis of arginine from citrulline (van de Poll
et al, 2004). Citrulline synthesized in the small intestine reaches
kidney for further metabolism by urea cycle reactions, thereby
contributing to inter-organ amino acid metabolism. The spleen is an
important hematopoietic organ, and synthesis of dolichol and
cholesterol from acetate are important indicators of this process
(Potter et al, 1981). The human skin is mainly responsible for the
synthesis of vitamin D from 7-dehydrocholesterol in multiple reac-
tion steps (Chen et al, 2007). These physiological functions and
their representative biochemical reactions were set as metabolic
tasks for each organ (Table EV1).
Bile composition Bile salts aid in the digestion and absorption of fat
constituents through their micellar properties (Murray et al, 2009).
Recon3D describes the human metabolism of bile acids comprehen-
sively (Brunk et al, 2018). On an organ level, bile is synthesized in
the liver and drained into the gallbladder, via the bile duct. The gall-
bladder stores the bile constituents and releases it into the intestinal
lumen, i.e., into the duodenum (first part of small intestine) for effi-
cient digestion and absorption of food. To capture the bile composi-
tion, we used a large-scale proteomic analysis of human bile, which
also measured metabolites in the human bile (Fuda et al, 2006;
Farina et al, 2009). Conclusive evidence concerning their presence
in bile was available for 84 exchanged metabolites in the Recon3D*
model; and for 459 exchanged metabolites, absence in the bile was
concluded (Table EV7). The remaining transport reactions into the
bile duct, without evidence of presence or absence, were uncon-
strained and algorithmically added when extracting the subnetworks
depending on their secretion from the gallbladder and its internal
metabolism. The storage (aka demand) reactions for 26 bile salts
were added to the gallbladder.
Recon3D* exchange metabolites present/absent in diet Comprehen-
sive information for the presence in the diet was found for 300
metabolites, and for 50 metabolites the absence in the diet was
reported. For the remaining exchange metabolites, no information
could be found in the literature. Hence, these were left uncon-
strained in the meta-reconstruction (Table EV10).
Metabolomic data The WBM reconstructions account for 13 biofluid
compartments (Table 2). The core reaction set accounted for
biofluid-specificity of 1,105 metabolites such that they were incorpo-
rated into the respective biofluid compartments (i.e., in the blood
circulation, portal blood, cerebrospinal fluid, feces, and urine). This
was represented by adding the corresponding demand reactions to
the biofluids in the meta-reconstructions (see above). This informa-
tion was extracted from various literature references as well as data-
bases, including the Human Metabolome database (Wishart et al,
2013) (Table EV8). Many of these metabolites have been reported to
be changed in pathological states, and highlight the potential of the
WBM reconstructions in capturing the known biomarkers and
prediction of new ones.
Transport reaction information Our previous work on human
membrane transporters (Sahoo et al, 2014) served as a compendium
of transport proteins. These transport proteins were noted with their
organ distribution from the relevant scientific literature (Table EV5).
Again, the GPR associations within Recon3D* model were used, and
the corresponding transport reactions were extracted and incorpo-
rated into the core reaction set of the specific organ.
Conclusive evidence for the presence of 166 transport proteins
distributed across 26 organs formed the transport protein part of the
core reaction set. For the remaining organs, the presence of trans-
port proteins was derived from HPA and HPM. While the presence
of the transport protein and its associated reaction was included in
the core reaction set, the non-occurrence was ignored. This is
because the absence of a transport protein across an organ or tissue
is difficult to establish. Interestingly, amino acids transport proteins,
ABC transporters, and lipid transporters were found to be more
ubiquitously expressed across organs. Most transport protein infor-
mation was found for kidney, brain, liver, heart, and skeletal
muscle, while for hematopoietic cells (e.g., red blood cells and
platelets), the least information could be found. We enabled the
secretion of mucin degradative products, glycans, and ethanolamine
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into the large-intestinal lumen from the colon (Chang et al, 2004;
Fabich et al, 2008).
Defining the blood–brain barrier We represented the blood–brain
barrier in the WBM reconstructions. The brain is separated from
the blood/extracellular compartment by the blood–brain barrier
(Redzic, 2011). This barrier formed by the brain endothelial cells
and exhibits restricted entry of small molecules. Molecules with a
molecular mass below 500 Da and possessing high lipid solubility
can enter the brain (Pardridge, 2005). This information was used to
add the blood–brain barrier transport reactions to the core reaction
set (Table EV9). 240 metabolites have been reported not to pass the
blood–brain barrier, which includes lecithin, triglycerides, lysole-
cithin, and cholesterol (Pardridge & Mietus, 1980; Redzic, 2011).
Thus, the corresponding blood–brain barrier transport reactions
were constrained to zero in the meta-reconstructions, thereby elimi-
nating them from the WBM reconstructions. The remaining trans-
port reactions were unconstrained enabling their addition during
the subnetwork generation process. Their addition, therefore,
depended on the internal metabolic architecture of the brain (and
spinal cord).
Biomass reactions The WBM reconstructions contain three different
versions of the biomass reaction. These are (i) biomass_reaction,
(ii) biomass_maintenance, and (iii) biomass_maintenance_noTrTr.
The biomass_reaction is the general biomass reaction as in
Recon3D* model, biomass_ maintenance is same as biomass_reac-
tion except for the nuclear deoxynucleotides, and biomass_mainte-
nance_noTrTr, where _noTrTr stands for no transcription and
translation, is devoid of amino acids, nuclear deoxynucleotides, and
cellular deoxynucleotides except for adenosine-triphosphate.
The biomass reaction was retained only for tissues/organs
known to possess regenerative capacity, i.e., liver (Malhi et al,
2002), heart (Senyo et al, 2013), and kidney (Li & Wingert, 2013).
For the remaining organs, only the biomass_maintenance reaction
was added, requiring the maintenance of cellular metabolic pro-
files, i.e., the organs capability to synthesize all the biomass
components except the nuclear deoxynucleotides. The biomass_-
maintenance_noTrTr reaction may be used to model fasting condi-
tions, as amino acids if stored intracellularly, increase the osmotic
pressure, necessitating their rapid catabolism (Lanham-New et al,
2013).
In particular, the biomass reactions were formulated as follows:
“biomass_maintenance: 20.6508 h2o[c] + 20.7045 atp[c] + 0.385
87 glu_L[c] + 0.35261 asp_L[c] + 0.036117 gtp[c] + 0.50563 ala_L
[c] + 0.27942 asn_L[c] + 0.046571 cys_L[c] + 0.326 gln_L[c] + 0.5
3889 gly[c] + 0.39253 ser_L[c] + 0.31269 thr_L[c] + 0.59211 lys_L
[c] + 0.35926 arg_L[c] + 0.15302 met_L[c] + 0.023315 pail_hs[c] +
0.039036 ctp[c] + 0.15446 pchol_hs[c] + 0.055374 pe_hs[c] + 0.
020401 chsterol[c] + 0.002914 pglyc_hs[c] + 0.011658 clpn_hs[c] +
0.053446 utp[c] + 0.27519 g6p[c] + 0.12641 his_L[c] + 0.15967
tyr_L[c] + 0.28608 ile_L[c] + 0.54554 leu_L[c] + 0.013306 trp_L
[c] + 0.25947 phe_L[c] + 0.41248 pro_L[c] + 0.005829 ps_hs
[c] + 0.017486 sphmyln_hs[c] + 0.35261 val_L[c] -> 20.6508 h
[c] + 20.6508 adp[c] + 20.6508 pi[c] + lipid_membrane[c] + pro-
teome[c] + transcriptome[c] + biomass_maintenance_dummy_
objective”
where the lipid_membrane[c] is degraded via the reaction
“LIPID_DEGRx: lipid_membrane[c] -> 0.023315 pail_hs[c] +
0.154463 pchol_hs[c] + 0.055374 pe_hs[c] + 0.020401 chsterol[c] +
0.002914 pglyc_hs[c] + 0.011658 clpn_hs[c] + 0.005829 ps_hs
[c] + 0.017486 sphmyln_hs[c]”
the proteome[c] is degraded via the reaction
“PROTEOME_DEGRx: proteome[c] -> 0.385872 glu_L[c] + 0.
352607 asp_L[c] + 0.505626 ala_L[c] + 0.279425 asn_L[c] + 0.046
571 cys_L[c] + 0.325996 gln_L[c] + 0.538891 gly[c] + 0.392525
ser_L[c] + 0.31269 thr_L[c] + 0.592114 lys_L[c] + 0.35926 arg_L
[c] + 0.153018 met_L[c] + 0.126406 his_L[c] + 0.159671 tyr_L
[c] + 0.286078 ile_L[c] + 0.545544 leu_L[c] + 0.013306 trp_L
[c] + 0.259466 phe_L[c] + 0.412484 pro_L[c] + 0.352607 val_L[c]”
and the transcriptome[c] is degraded via the reaction
“TRANSCRIPTOME_DEGRx: transcriptome[c] -> 0.053446 amp
[c] + 0.039036 cmp[c] + 0.036117 gmp[c] + 0.053446 ump[c]”.
Finally, the biomass_maintenance_dummy_objective is part of
the whole-body biomass reaction, which is defined as:
“Whole_body_objective_rxn: 21.4286 Adipocytes_biomass_mainte-
nance_dummy_objective + 0.02 Agland_biomass_maintenance_-
dummy_objective + 2 Brain_biomass_maintenance_dummy_objective +
0.428571 Colon_biomass_maintenance_dummy_objective + 0.472857
Heart_biomass_maintenance_dummy_objective + 0.442857 Kidney_
biomass_maintenance_dummy_objective + 2.57143 Liver_biomass_
maintenance_dummy_objective + 0.765714 Lung_biomass_mainte-
nance_dummy_objective + 40 Muscle_biomass_maintenance_dummy_
objective + 0.142857 Pancreas_biomass_maintenance_dummy_
objective + 0.0228571 Prostate_biomass_maintenance_dummy_
objective + 0.000171429 Pthyroidgland_biomass_maintenance_dummy_
objective + 0.000465714 Retina_biomass_maintenance_dummy_
objective + 0.0428571 Scord_biomass_maintenance_dummy_objective +
0.914286 sIEC_biomass_reactionIEC01b_dummy_objective + 3.71429
Skin_biomass_maintenance_dummy_objective + 0.257143 Spleen_
biomass_maintenance_dummy_objective + 0.214286 Stomach_biomass_
maintenance_dummy_objective + 0.05 Testis_biomass_maintenance_
dummy_objective + 0.0285714 Thyroidgland_biomass_maintenance_
dummy_objective + 0.0642857 Urinarybladder_biomass_mainte-
nance_dummy_objective + 0.00212143 Bcells_biomass_maintenance_
dummy_objective + 0.0117857 CD4Tcells_biomass_maintenance_
dummy_objective + 0.00353571 Nkcells_biomass_maintenance_
dummy_objective + 0.00392857 Monocyte_biomass_maintenance_
dummy_objective + 0.0285714 Platelet_biomass_maintenance_
noTrTr_dummy_objective + 3.53571 RBC_biomass_maintenance_
noTrTr_dummy_objective + 0.0142857 Gall_biomass_maintenance_
dummy_objective ->”
Please note that the stoichiometric coefficients in the “Whole_
body_objective_rxn” can vary between sex and individuals, depending
on their organ fractions, which are either derived from experimental
data (e.g., whole-body scans), or calculated using phenomenological
methods (see Dataset EV2: 3.2 for more details) (Young et al, 2009).
Published metabolic reconstructions
For the red blood cell (Bordbar et al, 2011b), the adipocytes (Bord-
bar et al, 2011a), the small intestine (Sahoo & Thiele, 2013), and
the liver (Gille et al, 2010), genome-scale metabolic reconstructions
have been published; hence, their reactions were also used for
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defining present reactions in the corresponding organs of the WBM
reconstructions. Note that these reconstructions have been assem-
bled based on Recon 1 (Duarte et al, 2007).
The published red blood cell reconstruction has been assembled
using multiple proteomic data sets (Bordbar et al, 2011b). The
published adipocyte reconstruction was generated by tailoring Recon
1 based on genome annotation data, physiological, and biochemical
data from online databases (e.g., KEGG (Okuda et al, 2008), NCBI,
UniProt (Consortium, 2012b), and BRENDA (Scheer et al, 2011), and
literature (Bordbar et al, 2011a). The liver/hepatocyte reconstruction
has been built through manual curation of the relevant scientific litera-
ture, using Recon 1 and KEGG as starting points (Gille et al, 2010).
Additionally, gene expression data sets of normal human liver
samples have served as a secondary line of evidence (Gille et al,
2010). The small intestinal epithelial cell reconstruction (Sahoo &
Thiele, 2013) has been assembled using primary literature, organ-
specific books, and databases. Since the small intestinal epithelial cell
model maintained different extracellular compartments representing
the apical and basolateral polarity of the cell, the reactions were added
as such to the core set. However, the GPR association was updated
with those used in the Recon3D* model.
Mapping of the reaction content in these published reconstruc-
tions onto Recon3D* was done manually using the reaction abbre-
viation, reaction description, and reaction formula. In the case of
the adipocyte, the blood compartment was replaced with the extra-
cellular compartment to find the correct matches with the
Recon3D* reactions. Additionally, the published adipocyte model
(Bordbar et al, 2011a) contained a lumped version of the fatty acid
oxidation reactions; hence, the corresponding un-lumped versions
were mapped onto Recon3D*. The mapped reactions of all four
reconstructions were added to the core reaction set, after adding the
corresponding organ-specific prefix to the reaction abbreviations.
Algorithmic generation of draft sex-specific WBM reconstructions
from the tailored meta-reconstructions
To achieve the algorithmic generation of draft sex-specific WBM
reconstructions from the tailored draft meta-reconstructions, we
used the fastCore algorithm (Vlassis et al, 2014). Briefly, fastCore
takes as input a (meta-)metabolic reconstruction and the set of core
reactions, known to be active in the network, to identify a flux-
consistent subnetwork containing all core reactions (as long as they
are flux consistent) and a minimal number of additional, flux-
consistent reactions.
We considered for each sex two different scenarios and defined
constraints on the meta-reconstructions accordingly. In the end, we
obtained four meta-reconstructions.
First, a feeding condition was defined, in which all dietary
exchange reactions were open (i.e., the lower bound was set to –
inf and the upper bound was set to zero) and the storage of
metabolites in the various organs was enabled (lower bound on
the sink reactions were set to be zero and the upper bound was
set to be 1,000,000 mmol/day/person).
Second, a fasting condition was defined, in which all dietary
uptake reactions were closed (lower and upper bound were set to
zero) but access to stored metabolites from the different organs
was enabled (sink reactions had a lower bound of
1,000,000 mmol/day/person and an upper bound of zero).
Using these four differently setup meta-reconstructions along with
the corresponding (i.e., sex-specific) core reaction sets and the
fastCore algorithm, we generated four flux-consistent subnetworks.
We then removed the demand reactions for the biofluid metabolites,
defined all reactions present in each subnetwork to be the core reac-
tion set for the given setup, and repeated the extraction of flux-consis-
tent subsets from the meta-reconstructions. By doing so, we also
enforced that at least one reaction could either transport or excrete a
given biofluid metabolite or that it is catabolized in at least one organ.
Finally, we joined the fasting and the feeding subnetworks for
each sex. The rationale for having the feeding and the fasting condi-
tion is that the human body can fast overnight, and thus the WBM
reconstructions should capture this capability regarding catabolic as
well as anabolic metabolic reactions. Note that the WBM reconstruc-
tions are not able to starve, as this would require the degradation of
muscle proteins, which we did not explicitly capture in Recon3D*,
and thus in the WBM reconstructions.
The fastCore adds a minimal number of additional reactions to the
core reaction sets to form the flux consistent, compact subnetwork.
Hence, the added reactions represent hypotheses of which reactions
and pathways would be needed to make the subnetworks flux consis-
tent, given a set of core reactions. It does not mean that the proposed
solution is biologically relevant. Consequently, after the generation of
the male and female draft WBM reconstructions, we manually
inspected that the added reactions were consistent with the current
knowledge about organ-specific metabolism. The core reactions and
the absence of organ-specific reactions were updated based on litera-
ture evidence, and the subnetwork generation was repeated.
As one example, we encountered genes/proteins that were
present in an organ-specific manner as per the human proteome
data set (Kim et al, 2014), but, which were not added to the respec-
tive organs in the draft WBM reconstructions by fastCore, due to
missing transport reactions. These reactions were subsequently
added to the human metabolic reconstruction, which ultimately
yielded Recon3D, and thus Recon3D* model. This is because the
development of Recon3D and the WBM reconstructions occurred in
parallel. In brief, for each of these instances where core reactions
were not added to the subnetwork, we analyzed them manually. A
typical example is the addition of the reactions SALMCOM and
SALMCOM2 to the core reaction set for colon, rectum, adrenal
gland, platelet, lung, heart, brain, retina, B cells, CD4 cells, CD8
cells, NK cells, testis, and prostate. While SALMCOM was correctly
added by fastCore to the liver, gallbladder, pancreas, and kidney, it
was missing in the remaining organs, despite proteomic expression
evidence. Hence, we added transport reactions for the participating
metabolites of SALMCOM and SALMCOM2, i.e., normetanephrine
(VMH ID: normete_L) and metanephrine (VMH ID: mepi) as well as
their demand reactions in the blood circulation, as both compounds
have been detected in blood and urine (HMDB00819, HMDB04063).
The addition of these transport reactions allowed the metabolites to
be transported across the whole body and excreted in the urine by
the kidney. Similar to the discussed case, many transport reactions
were added during the debugging process that enabled the whole-
body routing of phospholipids, cholesterol ester species, and acyl-
carnitines. These examples show that the WBM reconstructions can
be effectively used to investigate inter-organ metabolite cross-talk.
Overall, due to the complexity of the WBM reconstructions and
the large number of reactions (more than 80 k, Fig 1B), we iterated
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this process more than 100 times, each time focusing on different
organs or pathways (spanning one or multiple organs).
At the end of the reconstruction part that relied on fastCore, we
removed all artificial reactions from the WBM reconstructions, such
as sink/demand reactions for biofluid metabolites and the sinks for
metabolites of microbial origin in the lumen.
Refinement and curation of the WBM reconstructions
We then proceeded to further manually curate the reconstructions by
adding reactions that have not been included using fastCore but for
which biological evidence could be found in the literature (e.g.,
certain amino acid transport reactions). We also added transport
reactions for all metabolites present in the extracellular space of the
organs to the corresponding biofluids. For instance, certain metabo-
lites were present in the CSF compartment due to brain and spinal
cord metabolism but no corresponding transport reactions from CSF
[csf] to blood circulation [bc] were included by fastCore. Hence, we
added those reactions as the entire CSF drains into the blood circula-
tion. Again, the reason that such reactions were not included into the
reconstructions by fastCore as it returns a most compact subnetwork.
Moreover, WBM model predictions were compared with organ-
specific data and known whole-body metabolic functions (e.g.,
multi-organ metabolism of glucose (Cori cycle), amino acid cycle
(Cahill cycle)). In this step, we added missing reactions to the sex-
specific draft WBM reconstructions. During the entire reconstruction
process, we performed the same quality control and assurance tests
as defined for genome-scale metabolic reconstructions (Thiele &
Palsson, 2010).
Conversion from reconstruction to condition-specific models
To ensure reproducibility of the presented work, and also to reduce
the number of supplemental tables, we provide a MATLAB (Math-
works, Inc) live script along with a PSCM toolbox, which is an
extension to the COBRA Toolbox (Heirendt et al, 2019) (to be
obtained from https://github.com/opencobra/cobratoolbox).
Unit of WBM models
The unit of all WBM model reactions is in mmol/day/person
(Harvey, 70 kg; Harvetta: 58 kg), if not stated differently.
Flux balance analysis
The conversion of a metabolic reconstruction into a condition-
specific model includes the transformation of the biochemical reac-
tion list into a computable, mathematical matrix format (S matrix),
where the columns correspond to reactions (variables) and the rows
correspond to the metabolites. If a metabolite (j) participates in a
reaction (i), the stoichiometric coefficient is entered in the corre-
sponding cell (j, i). Consequently, each row represents the mass-
balance equation for a given metabolite (dx/dt).
The conversion into a model also requires the imposition of
physicochemical constraints (e.g., mass conservation) and systems
boundaries, in the form of so-called exchange reactions (Palsson,
2015). The constraint-based modeling and reconstruction (COBRA)
approach assumes that the modeled system is in a steady state
(S.v = dc/dt = 0), where v is a flux vector for n reactions and dx/dt
the change in metabolite concentration (dx) over time (dt). The S
matrix gives rise to an underdetermined system of linear equations;
i.e., there are fewer equations (mass-balances) than variables (reac-
tion fluxes). Consequently, a polyhedral convex steady-state solu-
tion space contains all feasible steady-state solutions. By adding
further constraints (e.g., nutrient uptake rates, enzyme reaction
rates) to the model, one restricts the solution space to solutions that
are biologically relevant under this condition. Despite incomplete
knowledge about many reaction rates, kinetic parameters, metabo-
lite and enzyme concentrations, the COBRA approach permits the
computation of possible phenotypic properties of a metabolic
model, derived from a reconstruction.
In flux balance analysis (Orth et al, 2010), the modeled system is
assumed to be at a steady state (i.e., dx/dt = 0). Consequently, the
underlying mathematical problem is a linear programming problem
that can be efficiently solved and at a large scale, as only one global
optimal solution exists. The linear programming problem is formu-
lated as:
Optimize z ¼ cT:v
Such that S.v ¼ 0
lbi  vi ubi
where c is a vector (n,1), lb the lower bound, and ub the upper
bound of reaction i. For irreversible reactions, lb was set to
0 mmol/day/person and ub was > 0 mmol/day/person. In the case
of reversible reactions, lb was set to < 0 mmol/day/person. In
absence of specific simulation constraints, ub was set to the
arbitrary value 1,000,000 mmol/day/person, and lb to
-1,000,000 mmol/day/person. Uptake reactions (e.g., dietary
uptake reactions) were defined to have a negative flux value, while
excretion reaction (e.g., urine excretion, fecal excretion) was
defined to have a positive flux value.
Coupling constraints
Coupling constraints were implemented in the WBM reconstructions
as described previously (Thiele et al, 2010; Heinken et al, 2013).
Briefly, coupling constraints enforce that the flux through a set of
coupled reactions is proportional to a specified reaction (e.g.,
biomass reaction). The metabolic and transport reactions in every
organ were coupled to the respective organ’s biomass objective func-
tion (BOF). The coupling constraints prevent biologically implausi-
ble solutions where the reactions in an organs carry flux even
though the flux through the organ’s BOF is zero. They were realized
by implementing a coupling factor of 20,000 for each reaction. This
allowed each forward and reverse reaction to carry a flux of up to
20,000 and 20,000 times the flux through the BOF, respectively.
Flux variability analysis of the unconstrained and constrained
WBM models
We performed flux variability analysis (Gudmundsson & Thiele,
2010) on the unconstrained and physiologically constrained male
WBM model using a Julia implementation (Heirendt et al, 2017) of
flux balance analysis (Orth et al, 2010) by minimizing and maximiz-
ing each model reaction. The flux span of a reaction is defined as
maximal possible flux value (vmax,i) minus maximal possible flux
value for a reaction i (vmin,i): fluxSpani = (vmax,i  vmin,i).
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“Sanity checks” on the WBM and organ-specific reconstructions
Quality control and quality assurance tests, or sanity checks have
been compiled, expended, and implemented by the systems biol-
ogy research community (Thiele & Palsson, 2010; Agren et al,
2013; Fleming et al, 2016; Swainston et al, 2016; Brunk et al,
2018), e.g., in MEMOTE (preprint: Lieven et al, 2018) and in the
COBRA Toolbox (Heirendt et al, 2019). We ensured that the
whole-body metabolic reconstructions, and the organ-specific
reconstructions, passed the quality control and quality assurance
tests implemented in the COBRA Toolbox (Heirendt et al, 2019).
Additionally, we ensured that the organ-specific reconstructions
passed further quality control and quality assurance tests
(Tables 3 and EV19).
We converted the WBM reconstructions into computational
models (see also, Simulation details). First, we tested for secretion
or production of metabolites when all the exchanges and sinks were
closed (see Simulation details). We shall refer to this test as leak
test. Thereafter, the models were tested for carrying non-zero fluxes
for reactions known to be required for important metabolic func-
tions. We refer to these latter tests as metabolic function tests (see
Simulation details).
Leak tests The WBM reconstructions were tested for thermodynami-
cally infeasible loops that could generate metabolites or compounds
when no mass enters the model. Such a test was done in two steps.
Firstly, all the exchange, sink, and demand reactions were
constrained to zero for the lower bound. Then, all the exchange
reactions were optimized to check whether the model was carrying
any non-zero flux. After that, the biomass was optimized to check
whether the model was carrying any zero flux. Secondly, a demand
reaction for each compartment-specific metabolite in the model was
created and optimized. The basic purpose of running such a leak
test was to check whether the model can generate anything from
nothing. In case any of the demand or exchange reactions carry a
non-zero flux, the respective reaction was optimized while minimiz-
ing the Euclidian norm (Heirendt et al, 2019). Note that both
Recon3D model and also Recon3D* model passed the leak test, as
did the WBM reconstruction derived organ-specific models (see
Dataset EV2: 3.7).
Metabolic function tests Each organ-specific reconstruction in the
organ compendium has been tested for being able to have a non-
zero optimal flux value for up to 460 metabolic functions
(Table EV19). Please note that not all organs were required to carry
a non-zero optimal flux value for all 460 metabolic functions, as
each organ has its own primary metabolic functions.
ATP yield We also tested each organ model for the ATP yield and
flux through the ATP synthetase for 15 carbon sources under aero-
bic and anaerobic conditions in accordance with the tests introduced
by (Swainston et al, 2016; Table EV20).
Computing considerations when working with the WBM models
In order to run a flux variability analysis on such large-scale models
efficiently, dedicated high-performance was required. Most high-
performance computers have computing nodes with a relatively
high base frequency per core, but with a low memory per node
ratio. However, in order to perform large-scale biological simula-
tions efficiently, a high-memory computing node is recommended
with memory around 768 GB. The entire model must be able to be
loaded into memory together with the result files, which may
occupy more than 10–20 times the original model size. Memory
access speed was critical to load the model and perform mathemati-
cal operations quickly. It is recommended that the computing node
has a state-of-the-art dual processor with 18 cores (2 threads per
core) or more. In order to perform efficient flux variability analysis
on the WBM models with acceptable solution times, it is recom-
mended to run the optimization problems on all cores, each spawn-
ing 2 threads.
In addition to appropriate hardware, appropriately tuned soft-
ware was important. For large-scale models, poorly performing code
and an untuned solver are bottlenecks. As the optimization solver
accounts for most of the simulation time, parameter tuning together
with an appropriate interface are critical. The Tomlab interface is
recommended when interfacing the industrial-quality CPLEX solver
from MATLAB. Some analyses that were computing intensive, such
as flux variability analysis, were run from MATLAB, but the solver
is interfaced directly through a compiled MEX interface written in C.
The newly developed Julia language has proven itself to be a valu-
able alternative in launching a multi core flux variability analysis
(Heirendt et al, 2017), in particular for launching the analysis across
multiple nodes.
Simulation details
Please refer to the accompanying Matlab LiveScript and its html
version. Dataset EV2. The PSCM Toolbox contains all information,
Table 3. Lists of tests performed for all organ models derived from
the WBM reconstructions.
Number Quality assurance and quality control tests
1 “fastLeakTest”
2 “Exchanges, sinks, and demands have lb = 0, except h2o”
3 “Exchanges, sinks, and demands have lb = 0, except h2o
and o2”
4 “Exchanges, sinks, and demands have lb = 0, allow DM_
atp_c_ to be reversible”
5 “Exchanges, sinks, and demands have lb = 0, test flux through
DM_h[m] (max)”
6 “Exchanges, sinks, and demands have lb = 0, test flux through
DM_h[c] (max)”
7 “Exchanges, sinks, and demands have lb = 0, ub of EX_h[e]
= 0, test flux through DM_h[c] (min)”
8 “Test metabolic objective functions with open sinks”
9 “Test metabolic objective functions with closed sinks (lb)”
10 “Compute ATP yield”
11 “Check duplicate reactions”
12 “Check empty columns in rxnGeneMat”
13 “Check that demand reactions have a lb >= 0”
14 “Check consistency of model.rev with model.lb”
15 “Check whether singleGeneDeletion runs smoothly”
16 “Check for flux consistency”
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To analyze the prediction accuracies and compare them across
models and IEMs, the predictions for each metabolite were catego-
rized (increased, inconclusive, and decreased) according to the
simulation results (Table EV16). Then, the agreement in percentage
with the in vivo measurements was calculated for Recon3D*,
Harvey, and Harvetta separately. Moreover, to deliver a metric
taking agreement by chance into account, Cohen’s kappa and corre-
sponding confidence intervals were calculated. For deriving p-
values on prediction accuracies, multinomial logistic regressions
were utilized with in vivo observations as response variable (three
categories: increased/inconclusive/decreased) and in silico predic-
tion (three categories: increased/inconclusive/decreased) as the
predictor. Finally, respecting potential dependencies of predictions
coming from the same IEM, the agreement percentages per IEM was
calculated. For example, if four of five biomarkers in a certain IEM
were correctly predicted, the agreement percentage would be 80%.
The models (Harvey/Harvetta vs Recon3D*) were then tested
against each other using a non-parametric sign test with agreement
percentages per IEM as the response variable. This test effectively
provided statistical inference on the question of whether Harvey/
Harvetta showed higher accuracy in predicting biomarkers per IEM
in comparison to Recon3D* in a majority of IEMs. All statistical
calculations were performed in STATA 14/MP.
BMR predictions
To validate the WBM-based BMR predictions, we calculated the
Pearson correlations and corresponding R-squared values of the
WBM predictions when regressing them on the empirically
measured BMRs from (Prentice et al, 1986) in 13 women by stan-
dard linear ordinary least squares (OLS) regression. The provided
fat-free body mass was utilized to adjust the muscle and adipocyte
coefficients in the whole-body maintenance reaction. To optimize
the prediction, we variegated systematically the ATP coefficient of
the muscle biomass maintenance. Then, the parametrization of the
WBM predictions was validated in an independent data set (Lour-
eiro et al, 2015), which consisted of six female and 16 male
athletes. The measured BMRs were the response variable, while
the WBM predictions were the predictor of interest. We also
allowed for sex-specific intercepts by including sex as a covariate
into the standard linear OLS regression equation. Once again, the
correlations and R-squared values regarding the empirically
measured BMR were calculated. The prediction accuracies opera-
tionalized by the Pearson correlations were then compared with
the accuracies of estimations based on sex, height, and weight,
such as the Mifflin-St Jeor equations. Further, for statistical infer-
ence, we fitted in the larger data set (Loureiro et al, 2015) a multi-
variable regression using the measured BMR as the response
variable and the WBM predictions as well as the Mifflin-St Jeor
predictions as the predictor variables. We investigated whether
adding the Mifflin-St Jeor predictions to the WBM predictions or
vice versa increased the overall model-fit via likelihood ratio tests.
This procedure derived inference on the question of whether the
WBM predictions contain information not represented in the Mif-
flin-St Jeor equation and vice versa. The calculations were
performed in STATA 14/MP.
Microbiome host interactions
To analyze the relation between microbiome traits and fluxes in the
organ-specific reactions, we calculated the maximal fluxes through
the liver sulphotransferase, the liver alcohol dehydrogenase, and the
colonic carboxylic acid:CoA ligase. Then, we performed OLS regres-
sions with the fluxes as the dependent variable and the Bacteroide-
tes/Clostridia ratio as the predictor, allowing for non-linear
transformations of the predictor using multivariable fractional poly-
nomials. Besides the classical parametric test on the fit of the regres-
sion models, we used two non-parametrical methods to assess the
significance of the regression models in sensitivity analyses. First,
we used bootstrapping using 4,000 replications to determine p-
values. Second, we used quantile regression as an outlier robust
method. The full results can be found in Table EV18.
Data availability
Modeling computer scripts:
• Physiological and stoichiometrically constrained modeling
(PSCM) toolbox: GitHub (https://opencobra.github.io/cobratoolb
ox/stable/).
• Constraint-based reconstruction and analysis (COBRA) toolbox:
GitHub (https://opencobra.github.io/cobratoolbox/stable/).
• Microbiome modeling toolbox: GitHub (https://opencobra.github.
io/cobratoolbox/stable/).
Computational models:
• Whole-body metabolic reconstructions: Virtual Metabolic Human
database (https://www.vmh.life/#downloadview).
• Microbial metabolic reconstructions: Virtual Metabolic Human
database (https://www.vmh.life/#downloadview).
• Preecomputed results: https://github.com/ThieleLab
Expanded View for this article is available online.
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